- Headquarters
- Zug, Switzerland · Europe
- Value chain
- Research & IP(Research & design)
- What that means
- Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
- Founded
- 2013
- Ownership
- Listed
- Listing
- Nasdaq:CRSP on Google Finance
- Website
- crisprtx.com
- Relevance
- Very high at its strongest, in Synthetic Biology & Genetic Engineering
Zug, SwitzerlandIn 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Research · listed #7 of 50
Co-developer with Vertex of Casgevy, the first approved CRISPR-based gene-editing medicine (2023).
Relevance: Co-developed first approved CRISPR therapy Casgevy